Results 11 to 20 of about 27,603 (292)
Demographics, Usage Patterns, and Safety of Male Users of Clomiphene in the United States
The World Journal of Men's Health, 2020 Purpose: The aim of this study was to characterize the demographics, usage patterns and complication rates of clomiphene use in male patients. Materials and Methods: We retrospectively analyzed male patients from ages 20 to 55 years old who were ...
David P. Guo +4 more
doaj +2 more sources
Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome [PDF]
New England Journal of Medicine, 2014 BACKGROUND Clomiphene is the current first-line infertility treatment in women with the polycystic ovary syndrome, but aromatase inhibitors, including letrozole, might result in better pregnancy outcomes. Full Text of Background...
Alvero, Ruben +22 more
core +3 more sources
Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome [PDF]
Human Reproduction, 2017 STUDY QUESTION: Would letrozole as a primary ovulation induction agent generate better pregnancy rates than clomiphene citrate (CC) in subfertile women with anovulatory polycystic ovarian syndrome (PCOS)? SUMMARY ANSWER: Participants receiving letrozole
Amer, Saad A. +4 more
core +3 more sources
Clomiphene citrate for male infertility: A systematic review and meta‐analysis
Andrology, 2023 Male infertility is a prevalent and worldwide problem with various difficulties in treatment. Clomiphene citrate is a selective estrogen receptor modulator and may improve semen quality by stimulating hormone synthesis and spermatogenesis.
M. Huijben +5 more
semanticscholar +1 more source
Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry
Signal Transduction and Targeted Therapy, 2021 Dear Editor, COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still a threat to millions of lives worldwide. Although SARS-CoV-2 vaccines have been approved to reduce the severity and death associated with COVID-
Shulong Zu +9 more
semanticscholar +1 more source
Asian Journal of Medical Sciences, 2022 Background: A combination of controlled ovarian hyperstimulation and intrauterine insemination (IUI) remains an important treatment option for couple having infertility.
Rajib Roy +2 more
doaj +1 more source
Randomized interventional clinical trial to estimate the efficacy of clomiphene citrate versus letrozole in induction of ovulation in infertility [PDF]
New Indian Journal of OBGYN, 2022 Background and objectives: Anovulation accounts for 30-40% of female infertility. The treatment of choice is by ovulation induction. This study is to estimate effectiveness of clomiphene citrate versus letrozole in ovulation induction.
Yogindra Kumar Manohar Kabadi +1 more
doaj +1 more source
Journal of Psychosomatic Obstetrics and Gynecology, 2021 Objectives To investigate whether patients with polycystic ovary syndrome (PCOS) are at increased risk for incident schizophrenia and whether PCOS treatment (clomiphene, cyproterone, or metformin) affects the incidence of schizophrenia.
Shih-Fen Chen +3 more
doaj +1 more source
Medicine, 2020 Objective: To compare the effects of letrozole and human menopausal gonadotropin (HMG) in the treatment of patients with polycystic ovary syndrome (PCOS) resistant to clomiphene citrate (CC).
Shaoquan Shi +5 more
semanticscholar +1 more source
Pakistan Journal of Medical Sciences, 2020 Objective: This study was aimed to compare the clinical outcomes of ovulation induction (OI) by timed intercourse with letrozole (LTZ) and clomiphene citrate (CC). Methods: Three hundred and twenty-three patients with polycystic ovary syndrome (PCOS) who
M. Sakar, Süleyman Cemil Oğlak
semanticscholar +1 more source